|
Incidence of adverse events |
|||
| Adverse events |
Placebo (n = 23) |
100 mg/day 5-Loxin® (n = 24) |
250 mg/day 5-Loxin® (n = 23) |
|
|
|||
| Diarrhoea |
3 |
2 |
2 |
| Nausea |
1 |
3 |
2 |
| Vomiting |
1 |
1 |
1 |
| Abdominal pain |
4 |
2 |
2 |
| Pedal edema |
0 |
1 |
0 |
| Itching |
2 |
1 |
4 |
| General weakness |
2 |
4 |
2 |
| Constipation |
0 |
0 |
1 |
| Mild fever (up to 37.5°C) |
1 |
2 |
2 |
| Stomach burn |
4 |
0 |
3 |
| Allergya |
3 |
0 |
1 |
| Headache |
0 |
0 |
1 |
| Miscellaneousb |
9 |
2 |
6 |
| Sum of events |
30 |
18 |
27 |
|
aAllergy includes redness of skin and sinus allergy. bMiscellaneous group includes body pain, loss of hair, chest pain and eye infection. | |||
Sengupta et al. Arthritis Research & Therapy 2008 10:R85 doi:10.1186/ar2461 |
|||